Eli Lilly and (LLY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Eli Lilly and

    NYSE: LLY · Real-Time Price · USD
    726.85
    -16.06 (-2.16%)
    At close: Sep 05, 2025, 3:59 PM
    726.10
    -0.10%
    After-hours: Sep 05, 2025, 07:56 PM EDT

    Eli Lilly and Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 45.04B 34.12B 28.54B 28.32B
    Cost of Revenue
    		 8.42B 7.08B 6.63B 7.31B
    Gross Profit
    		 36.62B 27.04B 21.91B 21.01B
    Operating Income
    		 17.5B 10.79B 8.65B 7.93B
    Interest Income
    		 175.2M 173.6M 62.8M 25.4M
    Pretax Income
    		 12.68B 6.55B 6.81B 6.16B
    Net Income
    		 10.59B 5.24B 6.24B 5.58B
    Selling & General & Admin
    		 8.13B 6.94B 6.07B 6.14B
    Research & Development
    		 10.99B 9.31B 7.19B 6.93B
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 19.12B 16.25B 13.26B 13.07B
    Interest Expense
    		 780.6M 485.9M 331.6M 339.8M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 27.54B 23.34B 19.89B 20.39B
    Income Tax Expense
    		 2.09B 1.31B 561.6M 573.8M
    Shares Outstanding (Basic)
    		 900.61M 899.38M 950.18M 953.65M
    Shares Outstanding (Diluted)
    		 904.06M 903.28M 950.18M 953.65M
    EPS (Basic)
    		 11.76 5.83 6.57 5.85
    EPS (Diluted)
    		 11.71 5.80 6.57 5.85
    EBITDA
    		 15.23B 8.57B 8.66B 8.04B
    EBIT
    		 13.46B 7.04B 7.14B 6.5B
    Depreciation & Amortization
    		 1.77B 1.53B 1.52B 1.55B

    Add to Watchlist